Turkmenistan vs Western Pacific (WHO region): Measles-containing-vaccine second-dose (MCV2) immunization coverage
Turkmenistan
99.0%
in 2025
Western Pacific (WHO region)
86.0%
in 2025
Turkmenistan rank
1st
Western Pacific (WHO region) rank
4th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Turkmenistan
- Western Pacific (WHO region)
How they compare
Turkmenistan currently reports 99.0% against 86.0% in Western Pacific (WHO region), a difference of 13.0%.
That makes Turkmenistan's figure about 1.2 times Western Pacific (WHO region)'s.
Across all 26 years both countries report, Turkmenistan has been ahead every year.
Turkmenistan ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Turkmenistan | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.5% | 37.8% | 56.7% | Turkmenistan |
| 2010s | 99.0% | 86.7% | 12.3% | Turkmenistan |
| 2020s | 98.8% | 86.7% | 12.2% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Turkmenistan or Western Pacific (WHO region)?
- Turkmenistan, at 99.0% against 86.0% in Western Pacific (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Turkmenistan and Western Pacific (WHO region)?
- 13.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Turkmenistan and Western Pacific (WHO region)?
- 26 years are reported by both, from 2000 to 2025.
- How do Turkmenistan and Western Pacific (WHO region) rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Turkmenistan ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.